Liver Diseases Clinical Trial
Official title:
Children's Hospital of Chongqing Medical University
| NCT number | NCT04477967 |
| Other study ID # | 2018(120) |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | October 1, 2018 |
| Est. completion date | July 1, 2028 |
The purpose of the pediatric liver transplant biobank is to systematically collect clinical specimens from pediatric end-stage liver disease. It is expected to contribute to the research and development of paediatric end-stage liver disease in the future.
| Status | Recruiting |
| Enrollment | 500 |
| Est. completion date | July 1, 2028 |
| Est. primary completion date | January 1, 2021 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 1 Month to 18 Years |
| Eligibility |
Inclusion Criteria: 1. Children diagnosed with end-stage liver disease. 2. Liver transplantation in our hospital. 3. informed patient consent. 4. long-term follow-up in our hospital. Exclusion Criteria: No fixed contact information, difficult to follow up the patients. |
| Country | Name | City | State |
|---|---|---|---|
| China | Children's Hospital of Chongqing Medical University | Chongqing | Chongqing |
| Lead Sponsor | Collaborator |
|---|---|
| Children's Hospital of Chongqing Medical University |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Biological sample bank | A repository of biological samples from patients who will join the project, will be organised at the biobank center of the Children's Hospital of Chongqing Medical University(CHCMU) under the responsibility of the experienced staff at the Department of Hepatic. | 2 years | |
| Primary | Integrated health data platform | Collect patient clinical test information and establish diagnostic database. | 2 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05255042 -
Tissue Models for Liver Disease
|
||
| Completed |
NCT04473482 -
Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial
|
N/A | |
| Not yet recruiting |
NCT05120557 -
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
|
N/A | |
| Completed |
NCT02917408 -
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
|
||
| Recruiting |
NCT03773887 -
Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease
|
N/A | |
| Recruiting |
NCT00345930 -
DILIN - Prospective Study
|
||
| Completed |
NCT00148031 -
Improving Hepatitis C Treatment in Injection Drug Users
|
Phase 4 | |
| Terminated |
NCT00031135 -
Total Parenteral Nutrition-Associated Liver Disease
|
Phase 2 | |
| Completed |
NCT00005305 -
Hepatitis Delta Infections in Hemophiliacs
|
N/A | |
| Completed |
NCT00005304 -
Delta Hepatitis and Liver Disease in Hemophiliacs
|
||
| Completed |
NCT00222664 -
Qidong Hepatitis B Intervention Study
|
Phase 4 | |
| Recruiting |
NCT06195917 -
Robotic-assisted Percutaneous Transhepatic Puncture
|
N/A | |
| Recruiting |
NCT04551742 -
Social & Contextual Impact on Children Undergoing Liver Transplantation
|
||
| Completed |
NCT04782050 -
Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation
|
N/A | |
| Completed |
NCT03614039 -
Effect of Probiotic and Smectite Gel on NAFLD
|
N/A | |
| Recruiting |
NCT04518852 -
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
|
Phase 2 | |
| Recruiting |
NCT05499585 -
Treating Pediatric NAFLD With Nutrition
|
N/A | |
| Terminated |
NCT03396705 -
Liver Regeneration
|
||
| Completed |
NCT04341012 -
Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases
|
||
| Recruiting |
NCT05733832 -
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
|
N/A |